Activated CD56+ILC3s from donor and patient LN could acquire cytotoxic capacity producing IFN-γ or could promote a pro-tumor immune response inducing the production of tumor necrosis factor α (TNF-α) (Figure 2). This evidence concerns the gene TNF and neoplasm.